Dow Up 0.00% Nasdaq Up 0.09%

Epizyme, Inc. (EPZM)

-NasdaqGS
22.86 Up 0.31(1.37%) Nov 28, 1:00PM EST
Prev Close:22.55
Open:22.52
Bid:14.50 x 100
Ask:23.88 x 1100
1y Target Est:41.67
Beta:3.513
Earnings Date:Feb 25 - Mar 2 (Est.)
Day's Range:22.04 - 23.26
52wk Range:18.75 - 41.23
Volume:122,339
Avg Vol (3m):368,983
Market Cap:780.97M
P/E (ttm):N/A
EPS (ttm):-0.77
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for EPZM

Comparison

Symbol% ChgMkt Cap
EPZMUp 1.37%780.97M
GSKDown 0.15%111.67B
NVSUp 1.14%233.77B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.43
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.75
Quarterly EPS Est (Dec-14) :-0.53
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops personalized therapeutics for patients with genetically defined cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback